BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30454919)

  • 1. Current Medical Management of Pulmonary Tuberculosis.
    Belknap RW
    Thorac Surg Clin; 2019 Feb; 29(1):27-35. PubMed ID: 30454919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study.
    Li Q; Ou XC; Pang Y; Xia H; Huang HR; Zhao B; Wang SF; Zhao YL
    Tuberculosis (Edinb); 2017 Jul; 105():9-12. PubMed ID: 28610793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.
    Hamid Salim A; Aung KJ; Hossain MA; Van Deun A
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multidrug-resistant tuberculosis in Romania].
    Stoicescu IP; Didilescu C; Bercea O
    Pneumoftiziologia; 1997; 46(3):161-78. PubMed ID: 9654954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of multidrug-resistant tuberculosis].
    Tritar F; Daghfous H; Ben Saad S; Slim-Saidi L
    Rev Pneumol Clin; 2015; 71(2-3):130-9. PubMed ID: 25153927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in the management of tuberculosis.
    Sia IG; Wieland ML
    Mayo Clin Proc; 2011 Apr; 86(4):348-61. PubMed ID: 21454737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical features of tuberculosis in children and adolescents excreting drug-resistant Mycobacterium tuberculosis strains].
    Bekembaeva GS; Serikbaeva KS; Kastypkaeva DV
    Probl Tuberk Bolezn Legk; 2009; (6):13-6. PubMed ID: 19642567
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates.
    Broda A; Nikolayevskyy V; Casali N; Khan H; Bowker R; Blackwell G; Patel B; Hume J; Hussain W; Drobniewski F
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1273-1279. PubMed ID: 29675789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spot or early morning sample for mycobacterial culture: which?
    Das D; Dwibedi B; Kar SK
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):310-1. PubMed ID: 24670567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
    Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
    Kumar RS; Kumar AM; Claassens M; Banurekha VV; Sekar G; Venkatesan P; Swaminathan S
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?
    Badoum G; Saleri N; Dembélé MS; Ouedraogo M; Pinsi G; Boncoungou K; Bonkoungou V; Birba E; Miotto P; Migliori GB; Cirillo DM; Matteelli A
    Eur Respir J; 2011 May; 37(5):1283-5. PubMed ID: 21532018
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria.
    Kehinde AO; Adebiyi EO
    Niger J Physiol Sci; 2013 Dec; 28(2):187-91. PubMed ID: 24937395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.
    Bablishvili N; Tukvadze N; Avaliani Z; Blumberg HM; Kempker RR
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):676-8. PubMed ID: 25946358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid diagnosis of pulmonary tuberculosis and detection of drug resistance by combined simultaneous amplification testing and reverse dot blot.
    Chen Y; Zhang L; Hong L; Luo X; Chen J; Tang L; Chen J; Liu X; Chen Z
    J Clin Pathol; 2018 Jun; 71(6):498-503. PubMed ID: 29138284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.